Starling Oncology (STLNW) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | -90.20% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 134.78% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -125.96% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 342.67% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 90.75% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | -35.11% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | -9.38% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 65.38% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 30.31% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 214.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 214.47% |
| Mar 31, 2026 | 66.92% |
| Dec 31, 2025 | 183.85% |
| Sep 30, 2025 | -123.99% |
| Jun 30, 2025 | -2,660.16% |
| Mar 31, 2025 | -486.83% |
| Dec 31, 2024 | -65.04% |
| Sep 30, 2024 | 908.99% |
| Jun 30, 2024 | -97.30% |
| Mar 31, 2024 | 107.02% |
| Dec 31, 2023 | 112.56% |
| Sep 30, 2023 | 51.24% |
| Jun 30, 2023 | 143.55% |
| Mar 31, 2023 | 106.31% |
| Dec 31, 2022 | -145.75% |
| Sep 30, 2022 | 23.48% |
| Jun 30, 2022 | -155.87% |
| Mar 31, 2022 | -191.72% |
| Dec 31, 2021 | 3,919.58% |
| Sep 30, 2021 | -3,379.02% |